Metamark Genetics Adds $13M
Metamark Genetics, an oncology-focused molecular diagnostics company, has raised $13 million in Series B financing, it announced this week. Specifics of the round were not released.
6 November 2012•4 mins read
Metamark Genetics, an oncology-focused molecular diagnostics company, has raised $13 million in Series B financing, it announced this week. Specifics of the round were not released.
